Carmel Shachar
Executive director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
Executive director, The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School
David Locke & Carmel Shachar consider the impact of globalised medicine on withdrawal of treatment decisions in the UK
Show
8
Results
8
MOVERS & SHAKERS
NLJ Career Profile: Mark Hastings, Quillon Law
Mark Hastings, founding partner of Quillon Law, on turning dreams into reality and pushing back on preconceptions about partnership
Kingsley Napley—Silvia Devecchi
New family law partner for Italian and international clients appointed
Mishcon de Reya—Susannah Kintish
Firm elects new chair of tier 1 ranked employment department
NEWS
Talk of a reserved ‘Welsh seat’ on the Supreme Court is misplaced. In NLJ this week, Professor Graham Zellick KC explains that the Constitutional Reform Act treats ‘England and Wales’ as one jurisdiction, with no statutory Welsh slot
The government’s plan to curb jury trials has sparked ‘jury furore’. Writing in NLJ this week, David Locke, partner at Hill Dickinson, says the rationale is ‘grossly inadequate’
A year after the $1.5bn Bybit heist, crypto fraud is booming—but so is recovery. Writing in NLJ this week, Neil Holloway, founder and CEO of M2 Recovery, warns that scams hit at least $14bn in 2025, fuelled by ‘pig butchering’ cons and AI deepfakes
After Woodcock confirmed no general duty to warn, debate turns to the criminal law. Writing in NLJ this week, Charles Davey of The Barrister Group urges revival of misprision or a modern equivalent
Family courts are tightening control of expert evidence. Writing in NLJ this week, Dr Chris Pamplin says there is ‘no automatic right’ to call experts; attendance must be ‘necessary in the interests of justice’ under FPR Pt 25
Copyright © 2026 LexisNexis
